We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Conventional and biological immunosuppressants in vasculitis.
Best Practice & Research. Clinical Rheumatology 2018 Februrary
The following chapter outlines the main findings from clinical trials, which provide information on the current best evidence-based management of the myriad of conditions that comprise vasculitis. Glucocorticoids (GCs) have been the mainstay of treatment of large-vessel vasculitis since Birkhead et al. used intramuscular cortisone daily and obtained good results in patients with giant cell arteritis. Recent trial data offer the hope that future treatment regimens may not need to be quite reliant on steroids. The use of GCs remains central to the management of many of the vasculitides, but recent advances owing to well run and coordinated clinical trials are changing the management approach. The strategy of aggressive induction of remission followed by a period of maintenance therapy has been established for patients with anti-neutrophil cytoplasm antibody-associated vasculitis. It remains unclear whether prediction can be made regarding which presentations or phenotypes should be treated with which drug regimen and when patients are likely to relapse. Currently, maintenance therapy is indicated for 2 years but whether there can be better tailored strategies remains to be proven. This chapter focuses on the main types of vasculitis, describing first the evidence for conventional immunosuppressants and then evidence for the use of biologics. Non-pharmacologic approaches are discussed in the next chapter.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app